Evidence map›Paper›PMID 34708686›Full record

ArticleEmerging infectious diseases2021

Incidence Trends for SARS-CoV-2 Alpha and Beta Variants, Finland, Spring 2021.

Ravi Kant, Phuoc Truong Nguyen, Soile Blomqvist, Mert Erdin, Hussein Alburkat, Maija Suvanto, Fathiah Zakham, Veera Salminen, Viktor Olander, Minna Paloniemi and 22 more

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Genomic and epidemiological report of the recombinant XJ lineage SARS-CoV-2 variant, detected in northern Finland, January 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Ravi Kant
Phuoc Truong Nguyen
Soile Blomqvist
Mert Erdin
Hussein Alburkat
Maija Suvanto
Fathiah Zakham
Veera Salminen
Viktor Olander
Minna Paloniemi
Leena Huhti
Sara Lehtinen
Bruno Luukinen
Hanna Jarva
Hannimari Kallio-Kokko
Satu Kurkela
Maija Lappalainen
Hanna Liimatainen
Sari Hannula
Jani Halkilahti
Jonna Ikonen
Niina Ikonen
Otto Helve
Marianne Gunell
Tytti Vuorinen
Ilya Plyusnin
Erika Lindh
Pekka Ellonen
Tarja Sironen
Carita Savolainen-Kopra
Teemu Smura
Olli Vapalahti

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 Alpha and Beta variants became dominant in Finland in spring 2021 but had diminished by summer. We used phylogenetic clustering to identify sources of spreading. We found that outbreaks were mostly seeded by a few introductions, highlighting the importance of surveillance and prevention policies.

Indexed as

COVID-19SARS-CoV-2FinlandHumansIncidencePhylogenyAlpha variantBeta variantcoronavirus diseaseCOVID-19epidemiologyFinlandinfectious disease transmissionphylogenypublic health surveillancerespiratory infectionsSARS-CoV-2severe acute respiratory syndrome coronavirus 2vaccinationvaccinesviruses

Identifiers

PMID34708686
PMCPMC8632157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.